new IV bisphosphonate called Zometa (zoledronic acid)

October 2001

Novartis is now marketing a new IV bisphosphonate called Zometa (zoledronic acid).

It will be used as an alternative to Aredia (pamidronate)...for hypercalcemia and bone metastases in cancer patients.

Bisphosphonates lower serum calcium by inhibiting bone resorption. They also reduce bone pain and fractures due to bone metastases.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Electronic Rxs are coming
Diabetes new rapid-acting insulin analog called Novolog (insulin aspart)
Diabetes stronger warnings about heart failure with Avandia
Diabetes more aggressive guidelines for diabetes screening and management
Migraine Midrin is now a Schedule IV controlled drug
withdrawal symptoms when patients stop antidepressants
Men's Health whether Viagra (sildenafil) loses its effectiveness over time
Men's Health which BPH patients should get Proscar or an alpha-blocker
Tuberculosis Remicade and Enbrel could lead to increases in tuberculosis (TB).
Tuberculosis using rifampin WITH pyrazinamide for latent tuberculosis
Pediatrics if it's okay to drink a little alcohol occasionally during pregnancy
Pediatrics amantadine for children with autism or other developmental disabilities
Infectious Diseases Spectracef (cefditoren pivoxil), a new third generation cephalosporin
Hematology & Oncology new IV bisphosphonate called Zometa (zoledronic acid)
Hematology & Oncology glutamine for mucositis caused by chemotherapy
Hematology & Oncology Our CE Booklets on natural medicines
concerns about bioterrorism